Teaser Publikation SAKK 08/16

SAKK 08/16 provides promising findings regarding a new maintenance therapy for advanced prostate cancer

The phase II trial SAKK 08/16 conducted by the Swiss Group for Clinical Cancer Research (SAKK) and published in the Journal of Clinical Oncology (JCO) on February 8, 2023 provides information on the efficacy of darolutamide as a maintenance therapy.

SAKK 08/16 provides promising findings regarding a new maintenance therapy for advanced prostate cancer

The phase II trial SAKK 08/16 conducted by the Swiss Group for Clinical Cancer Research (SAKK) and published in the Journal of Clinical Oncology (JCO) on February 8, 2023 provides information on the efficacy of darolutamide as a maintenance therapy.